SHILPA MEDICARE
Back to Balance Sheet
|
SHILPA MEDICARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹260 Cr | ₹589 Cr | ₹345 Cr | ₹453 Cr | ₹561 Cr |
What is the latest Total Non-Current Liabilities ratio of SHILPA MEDICARE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹260 Cr |
| Mar2024 | ₹589 Cr |
| Mar2023 | ₹345 Cr |
| Mar2022 | ₹453 Cr |
| Mar2021 | ₹561 Cr |
How is Total Non-Current Liabilities of SHILPA MEDICARE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹260 Cr | -55.92 | |
| Mar2024 | ₹589 Cr | 70.79 | |
| Mar2023 | ₹345 Cr | -23.78 | |
| Mar2022 | ₹453 Cr | -19.34 | |
| Mar2021 | ₹561 Cr | - | |
Compare Total Non-Current Liabilities of peers of SHILPA MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHILPA MEDICARE | ₹12,118.4 Cr | -1.7% | 8.2% | 46.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
SHILPA MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHILPA MEDICARE | -1.7% |
8.2% |
46.5% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses